In utero antibiotics and obesity risk
Published on June 7th, 2019 by Christina Echegaray.
Summer 2019
Identifying risk factors for childhood obesity is necessary for developing prevention strategies. Previous studies of a potential association between antibiotic use during pregnancy and childhood obesity have had conflicting results.
William Heerman, MD, MPH and colleagues in the National Patient Centered Clinical Research Network (PCORnet) conducted a large retrospective cohort analysis to evaluate the possible association between antibiotic use during pregnancy and childhood obesity. PCORnet is a nationwide research network that enables multi-institutional research.
The investigators used electronic health records from seven health care institutions to study 53,320 mother-child pairs. They found that maternal antibiotic use during pregnancy was not associated with childhood obesity at age 5. They evaluated antibiotic exposure by trimester, total exposure and antibiotic type. The large number of mother-child pairs also facilitated study of sub-populations, such as children with complex health conditions.
Reporting in the International Journal of Obesity, the authors concluded that the long-term risk of childhood obesity from maternal antibiotic use during pregnancy appears to be negligible.
This research was supported through the Patient-Centered Outcomes Research Institute (PCORI) Program Award.
– by Leigh MacMillan
